Biopharmaceutical companies have announced an abundance of investment in their companies from US government sources recently, which adds to the flurry of new investment funds backing drug developers,
According to the Alzheimer’s Association, Alzheimer’s disease is the sixth leading cause of death in the US, and is the only one among the top 10 that cannot be prevented, cured or slowed. This year A
Oligomerix Inc. 3960 Broadway Suite 340D New York, NY 10032 Web Site: www.oligomerix.com Contact: Jack Pasini, Chief Commercial Officer Industry Segment: Biopharmaceuticals Business: Drugs f
Ocular Gene Therapy Sees The Light Recent scientific advances and some initial biotech successes have spurred investors to look again at gene therapy, an approach once considered all but dead. Gene t